{"id":"NCT02514473","sponsor":"Vertex Pharmaceuticals Incorporated","briefTitle":"A Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects With CF, Homozygous for the F508del-CFTR Mutation","officialTitle":"A Phase 3, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 6 Through 11 Years With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-07","primaryCompletion":"2016-09","completion":"2016-09","firstPosted":"2015-08-03","resultsPosted":"2017-10-23","lastUpdate":"2017-10-23"},"enrollment":206,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Cystic Fibrosis"],"interventions":[{"type":"DRUG","name":"VX-809","otherNames":["lumacaftor"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"VX-770","otherNames":["ivacaftor"]}],"arms":[{"label":"LUM/IVA","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the efficacy and safety of lumacaftor in combination with ivacaftor in subjects aged 6 Through 11 years with cystic fibrosis (CF), homozygous for the F508del CF transmembrane conductance regulator (CFTR) mutation","primaryOutcome":{"measure":"Absolute Change From Baseline in Lung Clearance Index 2.5 (LCI2.5) Through Week 24","timeFrame":"Baseline, Through Week 24","effectByArm":[{"arm":"Placebo","deltaMin":0.08,"sd":0.13},{"arm":"LUM/IVA","deltaMin":-1.01,"sd":0.13}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":53,"countries":["United States","Australia","Belgium","Canada","Denmark","France","Germany","Sweden","United Kingdom"]},"refs":{"pmids":["37983082","33331662","28606620"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":101},"commonTop":["Cough","Pyrexia","Infective pulmonary exacerbation of cystic fibrosis","Nasal congestion","Oropharyngeal pain"]}}